We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.59B
AUM Growth
+$41.6M
Cap. Flow
+$65.7M
Cap. Flow %
1.83%
Top 10 Hldgs %
58.03%
Holding
157
New
11
Increased
42
Reduced
36
Closed
13

Top Sells

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$83.4M
2
ZTO icon
ZTO Express
ZTO
+$28.7M
3
GILD icon
Gilead Sciences
GILD
+$23.3M
4
HCC icon
Warrior Met Coal
HCC
+$18.5M
5
SWKS icon
Skyworks Solutions
SWKS
+$9.89M

Sector Composition

Rank Sector Weight
1 Technology 27.52%
2 Consumer Discretionary 17.85%
3 Industrials 16.75%
4 Healthcare 13.27%
5 Materials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRS icon
51
Coherus Oncology
CHRS
$196M
$8.54M 0.24%
535,108
-40,402
-7% -$707K
GTH
52
DELISTED
Genetron Holdings Limited ADS
GTH
$8.03M 0.22%
438,881
+24,276
+6% +$805K
ALBO
53
DELISTED
Albireo Pharma Inc
ALBO
$7.35M 0.2%
315,662
+70,281
+29% +$1.87M
SYNH
54
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$7.33M 0.2%
71,397
-9,444
-12% -$907K
EPZM
55
DELISTED
Epizyme, Inc
EPZM
$7.06M 0.2%
2,822,936
+919,043
+48% +$3.61M
HCM icon
56
HUTCHMED
HCM
$2.17B
$6.71M 0.19%
191,156
+33,102
+21% +$1.08M
CRNC icon
57
Cerence
CRNC
$413M
$6.69M 0.19%
+87,329
New +$7.7M
MRUS
58
DELISTED
Merus
MRUS
$5.61M 0.16%
176,509
-63,528
-26% -$1.79M
YUMC icon
59
Yum China
YUMC
$16.3B
$5.44M 0.15%
109,179
ACIU icon
60
AC Immune
ACIU
$240M
$5.26M 0.15%
1,062,462
IMVT icon
61
Immunovant
IMVT
$8.25B
$5.25M 0.15%
615,900
+60,835
+11% +$502K
BIO icon
62
Bio-Rad Laboratories Class A
BIO
$9.42B
$4.9M 0.14%
6,485
MRNA icon
63
Moderna
MRNA
$23.6B
$4.88M 0.14%
+19,230
New +$5.62M
OMGA
64
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$4.7M 0.13%
414,513
-85,487
-17% -$1.63M
XGN icon
65
Exagen
XGN
$166M
$4.65M 0.13%
400,000
IMTX icon
66
Immatics
IMTX
$1.32B
$4.47M 0.12%
332,356
ASMB icon
67
Assembly Biosciences
ASMB
$529M
$4.45M 0.12%
159,125
+21,374
+16% +$701K
CYPH
68
Cypherpunk Technologies Inc
CYPH
$73.3M
$4.3M 0.12%
132,795
CTMX icon
69
CytomX Therapeutics
CTMX
$754M
$4.24M 0.12%
980,085
-98,018
-9% -$574K
WVE icon
70
Wave Life Sciences
WVE
$1.2B
$4.2M 0.12%
1,336,105
+559,984
+72% +$2.33M
PVLA
71
Palvella Therapeutics
PVLA
$2.27B
$3.89M 0.11%
12,854
ZYME icon
72
Zymeworks
ZYME
$1.67B
$3.86M 0.11%
235,299
+79,887
+51% +$1.67M
INBX
73
DELISTED
Inhibrx, Inc. Common Stock
INBX
$3.8M 0.11%
86,929
-16,654
-16% -$666K
TKNO icon
74
Alpha Teknova
TKNO
$347M
$3.47M 0.1%
169,237
+19,237
+13% +$427K
GRUB
75
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$3.44M 0.1%
319,228

Similar funds

Platinum Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Platinum Investment Management held 157 positions worth $3.59B, up 1.2% from $3.55B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Platinum Investment Management's Q4 2021 filing shows 11 new, 42 increased, 36 reduced and 13 closed positions. Its largest new stake was Iris Energy: 2,717,193 shares worth $43.9M. The largest sale was Louisiana-Pacific, an estimated $83.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Platinum Investment Management's largest Q4 2021 buy was Iris Energy: 2,717,193 shares worth $43.9M.
  • Platinum Investment Management added most to Roblox in Q4 2021, an estimated $52M increase.
  • Platinum Investment Management's biggest Q4 2021 reduction was ZTO Express, cutting an estimated $28.7M.
  • Platinum Investment Management fully exited Louisiana-Pacific in Q4 2021, selling an estimated $83.4M.
  • Platinum Investment Management's ten largest holdings make up 58% of its $3.59B portfolio in Q4 2021.
  • Platinum Investment Management opened 11 new positions and closed 13 in Q4 2021.
  • Platinum Investment Management's portfolio value rose 1.2% quarter-over-quarter to $3.59B.

Based on Platinum Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.